Cargando…
Extended normobaric hyperoxia therapy yields greater neuroprotection for focal transient ischemia-reperfusion in rats
BACKGROUND: Normobaric hyperoxia (NBO) therapy is neuroprotective in acute ischemic stroke. However, how long the NBO should last to obtain optimal outcome is still unclear. Reports show that ischemic penumbra blood supply may remain compromised for a long period after ischemia-reperfusion, which wo...
Autores principales: | Yuan, Zhongrui, Pan, Rong, Liu, Wenlan, Liu, Ke Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149308/ https://www.ncbi.nlm.nih.gov/pubmed/25177481 http://dx.doi.org/10.1186/2045-9912-4-14 |
Ejemplares similares
-
Normobaric hyperoxia-based neuroprotective therapies in ischemic stroke
por: Qi, Zhifeng, et al.
Publicado: (2013) -
Neuroprotective Effects of Normobaric Hyperoxia and
Transplantation of Encapsulated Choroid Plexus
Epithelial Cells on The Focal Brain Ischemia
por: Eslami, Maesumeh, et al.
Publicado: (2021) -
Normobaric hyperoxia plays a neuroprotective role after cerebral ischemia by maintaining the redox homeostasis and the level of connexin43 in astrocytes
por: Qi, Zhifeng, et al.
Publicado: (2022) -
Normobaric hyperoxia protects the blood brain barrier through inhibiting Nox2 containing NADPH oxidase in ischemic stroke
por: Liu, Wenlan, et al.
Publicado: (2011) -
Time course of neuroprotection induced by in vivo normobaric hyperoxia preconditioning and angiogenesis factors
por: Shahhoseini, Meisam, et al.
Publicado: (2017)